Samsara Vision’s SING IMT is a Galilean telescope implant designed to improve visual acuity and quality of life for patients with late-stage age-related macular degeneration (AMD). The design improves upon a 1st-generation miniature telescope device implanted in more than 600 patients living with late-stage AMD.

2021年8月24日 · The implantable miniature telescope (IMT) takes advantage of this fact by enlarging objects in the center of the visual field so they can be seen by the intact parts of the retina around the macula. The IMT has been tested in clinical trials and is approved by the FDA for patients with corrected vision of 20/160 – 20/800) that is caused by ...

At Samsara Vision, we recognize that central vision loss from late-stage age-related macular degeneration (AMD) can make it difficult for individuals to connect with the world around them. Our proprietary telescopic implant technology, SING IMT™, is intended to significantly improve central vision for late-stage AMD patients and help them ...

2025年1月13日 · This study represents a single-surgeon interventional case series of patients with bilateral late-stage AMD undergoing cataract surgery and SING IMT™ implantation.

The implantable miniature telescope (IMT) is an ophthalmic device developed to improve vision in individuals who have lost vision due to AMD. Once implanted, the IMT is used to enlarge objects in the central visual field and focus them onto healthy areas of the retina not affected by AMD, allowing individuals to recognize objects that they ...

The Implantable Miniature Telescope (IMT) is FDA approved in the United States and has a CE Mark for the European Union and the United Kingdom, and a therapeutic goods certificate from Australia. Samsara Vision’s new generation SING IMT received a CE mark for the European Union in 2020 (SING IMT is not currently FDA approved).

This article summarizes the mechanism and results for seven different IOLs designed to help patients with AMD: an implantable miniature telescope (IMT), IOL-VIP System, Lipshitz macular implant (LMI), sulcus-implanted Lipshitz macular implant, LMI-SI, Fresnel Prism Intraocular Lens, iolAMD and Scharioth Macula Lens.

2022年4月20日 · The CONCERTO trial will recruit older adults living with stable (non-active neovascularization), bilateral central scotomas (blind spots) due to late-stage AMD and fovea-involving geographic atrophy or disciform scar to receive a SING IMT™ in one eye.

2025年1月13日 · Addressing Unmet Treatment Needs in AMD Age-related macular degeneration (AMD) is a leading cause of permanent vision loss for people age 50 and older, and the number one cause of blindness in people age 65 years and older.

The telescopic implant is not a cure for late-stage age-related macular degeneration (AMD). It will not return your vision to the level you had before your AMD, nor will it completely make up for your vision loss. The goal is that you can see more in your central field of vision and that things come back to your life that you love to see and do.